{"id":1404,"date":"2026-09-08T11:31:30","date_gmt":"2026-09-08T09:31:30","guid":{"rendered":"https:\/\/atonco-pharma.com\/?p=1404"},"modified":"2026-09-11T13:55:46","modified_gmt":"2026-09-11T11:55:46","slug":"atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/","title":{"rendered":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED"},"content":{"rendered":"

The media outlet L’Usine Nouvelle<\/em> highlights our innovation strategy and the key role that Framatome \/ IBA’s future cyclotron in Nantes will play in developing our targeted cancer therapies.<\/p>\n

A pioneer in nuclear medicine built on the scientific legacy of Professor Jean-Fran\u00e7ois Chatal in Nantes, Atonco is set to reach a major milestone with the launch of a world first: the Phase 1 clinical trial of its drug candidate ATO-101.<\/p>\n

Link to the article:<\/strong> https:\/\/www.usinenouvelle.com\/energie\/nucleaire\/elle-va-profiter-du-futur-cyclotron-de-framatome-a-nantes-la-pepite-atonco-veut-revolutionner-la-medecine-nucleaire.QWQRI76TVZIP3K4PSQEVMRXQFA.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The media outlet L’Usine Nouvelle highlights our innovation strategy and the key role that Framatome \/ IBA’s future cyclotron in Nantes will play in developing our targeted cancer therapies. A pioneer in nuclear medicine built on the scientific legacy of Professor Jean-Fran\u00e7ois Chatal in Nantes, Atonco is set to reach a major milestone with the […]<\/p>\n","protected":false},"author":5,"featured_media":1402,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,48],"tags":[],"class_list":["post-1404","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorise","category-atonco-press-releases"],"yoast_head":"\nATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco\" \/>\n<meta property=\"og:description\" content=\"The media outlet L’Usine Nouvelle highlights our innovation strategy and the key role that Framatome \/ IBA’s future cyclotron in Nantes will play in developing our targeted cancer therapies. A pioneer in nuclear medicine built on the scientific legacy of Professor Jean-Fran\u00e7ois Chatal in Nantes, Atonco is set to reach a major milestone with the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-08T09:31:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-11T11:55:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png\" \/>\n\t<meta property=\"og:image:width\" content=\"756\" \/>\n\t<meta property=\"og:image:height\" content=\"619\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elise\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elise\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/\"},\"author\":{\"name\":\"Elise\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"headline\":\"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED\",\"datePublished\":\"2026-09-08T09:31:30+00:00\",\"dateModified\":\"2026-09-11T11:55:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/\"},\"wordCount\":97,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Image-usine-nouvelle.png\",\"articleSection\":[\"Actualit\u00e9\",\"Atonco press release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/\",\"name\":\"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Image-usine-nouvelle.png\",\"datePublished\":\"2026-09-08T09:31:30+00:00\",\"dateModified\":\"2026-09-11T11:55:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Image-usine-nouvelle.png\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Image-usine-nouvelle.png\",\"width\":756,\"height\":619},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/09\\\/08\\\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\",\"name\":\"Elise\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"caption\":\"Elise\"},\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/administration\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/","og_locale":"en_US","og_type":"article","og_title":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco","og_description":"The media outlet L’Usine Nouvelle highlights our innovation strategy and the key role that Framatome \/ IBA’s future cyclotron in Nantes will play in developing our targeted cancer therapies. A pioneer in nuclear medicine built on the scientific legacy of Professor Jean-Fran\u00e7ois Chatal in Nantes, Atonco is set to reach a major milestone with the […]","og_url":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/","og_site_name":"Atonco","article_published_time":"2026-09-08T09:31:30+00:00","article_modified_time":"2026-09-11T11:55:46+00:00","og_image":[{"width":756,"height":619,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png","type":"image\/png"}],"author":"Elise","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Elise","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/"},"author":{"name":"Elise","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"headline":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED","datePublished":"2026-09-08T09:31:30+00:00","dateModified":"2026-09-11T11:55:46+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/"},"wordCount":97,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png","articleSection":["Actualit\u00e9","Atonco press release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/","url":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/","name":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED - Atonco","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png","datePublished":"2026-09-08T09:31:30+00:00","dateModified":"2026-09-11T11:55:46+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/09\/Image-usine-nouvelle.png","width":756,"height":619},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2026\/09\/08\/atonco-in-the-spotlight-our-ambition-for-nuclear-medicine-highlighted\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATONCO IN THE SPOTLIGHT: OUR AMBITION FOR NUCLEAR MEDICINE HIGHLIGHTED"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa","name":"Elise","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","caption":"Elise"},"url":"https:\/\/atonco-pharma.com\/en\/author\/administration\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1404"}],"version-history":[{"count":4,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1404\/revisions"}],"predecessor-version":[{"id":1423,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1404\/revisions\/1423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1402"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}